Further enhancement of cellular uptake was observed when KYND-PEG-LP was combined with octaarginine (R8) on the surface of lipid membrane as dual-CPP ligand formulation, however, when PEG-LP combined with only R8, only negligible enhancement was observed. These findings suggest that two CPP ligands act in a synergistic fashion; therefore the dual-CPP ligand based liposomal formulation can be assumed to be an effective delivery system.
Introduction
Anthrax is a lethal infectious disease caused by Bacillus anthracis, a gram-positive, spore-forming, rod shaped bacterium that primarily infects herbivores such as cattle and deer (Keim and Smith, 2002; Turnbull, 2002) .
The anthrax toxin, a three-part toxin, consists of protective antigen (PA; 83 5 kDa, 735 amino acid residues), lethal factor (LF; 90 kDa), and edema factor (EF; 89 kDa), in which PA acts as a cellular receptor-binding component for tumor endothelial marker 8 (TEM8) and capillary morphogenesis protein 2 (CMG2) (Bradley et al., 2001; Scobie and Young, 2005; Werner et al., 2006) , where the segment of the amino acid sequence responsible for binding with 10 either TEM8 or CMG2, is still unclear, but would be in two different positions of PA. Due to its receptor binding capability, PA has the potential to serve a target for structure based drug therapies. PA has four domains in its structure, as follows: Domain 1 (residues 1-258), domain 2 (residues 249-487), domain 3 (residues 488-595) and domain 4 (residues 596-735) 15 (Petosa et al., 1997; Young and Collier, 2007) . Further studies on PA revealed that domain 4 (residues 596-735) directly binds to cellular receptors like TEM8 (Bradley et al., 2001; Petosa et al., 1997; Singh et al., 1991) . It has also been reported that domain 4 of PA (PA-D4) contains two loops in its structure in the form of a small loop (residues 679-693) and a large loop 20 (residues 704-723) and it was proposed that the large loop does not interact directly with receptors (Brossier et al., 1999; Varughese, et al., 1999) . This suggests that the small loop (residues 679-693) of PA-D4 would be more important for receptor binding and that residue 682 might play a major role in receptor recognition (Varughese et al., 1999) . The small loop of PA-D4 was 25 found to be the domain that is responsible for binding with TEM8. As a result, the small loop of PA-D4 appears to be an ideal candidate for utilization as a specific ligand for drug delivery systems.
Based on these considerations, we selected the amino acid residues [679] [680] [681] [682] [683] [684] [685] [686] [687] [688] 30 KKYNDKLPLY (abbreviated hereafter as KYND) from the small loop of PA-D4 for use as a novel ligand in the design of a selective targeting system. It is well known that liposomes are suitable nano-carriers that have the capacity to deliver drug particles to various target cells in vitro or diseased tissues in vivo (Puri et al., 2009; Du et al., 2007) . Hence, in our design, we 35 attached the selected KYND peptide to the top of poly ethylene glycol (PEG) of PEGylated liposomes and the cellular interaction efficiency of this ligand was evaluated based on the cellular uptake of the ligand-incorporated PEGylated liposomes. Cell-penetrating peptides (CPPs), short peptide sequences, are currently in use for drug and gene delivery 40 2009). CPPs, also known as protein transduction domains (PTDs) have the capability to enter into the cells either alone or in conjugation with small molecules or bulky cargos such as peptides, proteins, oligonucleotides, plasmid DNA (pDNA) or liposomes. In previous studies, we reported on the development of stearylated octaarginine (STR-R8) modified on the surface of 45 liposomes encapsulating plasmid DNA (pDNA), small interfering RNA (siRNA), or proteins, which can be efficiently internalized by cells (Kogure et al., 2004; Nakamura et al., 2007; Suzuki et al., 2007) . We recently proposed a dual-ligand liposomal delivery system modified with a specific ligand on the top of the PEG chain and STR-R8, as a CPP ligand, on the surface of 50 liposomes (Takara et al., 2010) . Even though the cellular uptake by target cells of PEGylated liposomes modified with either a specific ligand or STR-R8 was enhanced to only a minor extent, the dual-ligand formulation showed an increased specificity and its cellular uptake by target cells expressing target molecules was efficient, due to the synergistic effect of the 55 dual-ligand formulation.
In the present study, we also incorporated STR-R8 on the surface of the PEGylated liposomes along with the selected KYND peptide for use in a dual-CPP ligand formulation. The cellular uptake of the dual-CPP ligand 60 modified PEGylated liposomes was evaluated the data compared with the uptake for a single-CPP ligand version.
Materials and methods

Materials
Egg phosphatidylcholine (EPC), cholesterol (Chol), N-(lissamine rhodamine B sulfonyl)-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (rhodamine-DOPE), the cells were washed 3 times with 1 ml of ice-cold phosphate buffer saline (PBS) supplemented with heparin (20 units/ml) to completely remove the surface-bound KYND-PEG-LP, as reported previously (Khalil et al., 2004) and then treated with Reporter Lysis Buffer (Promega Corp., Madison, WI, USA) followed by centrifugation at 12,000 rpm for 5 min at 4 °C to remove debris. The cellular 140 uptake efficiency of the prepared rhodamine labeled LPs were determined by measuring the fluorescence intensity of rhodamine (excitation at 550 nm and emission at 590nm) using FP-750 Spectrofluorometer (JAS Co, Tokyo, Japan).
2.8. The uptake mechanism study of KYND modified PEG-LPs 145 2.8.1. Inhibition assay in presence of free peptide
To examine the effect of excess amount of free peptides on the cellular uptake of LPs, a cellular uptake experiment was performed in the presence of the free KYND peptide. Excess KYND peptide (25 fold v.s. peptide used in conjunction with modified LPs) in Kreb's buffer were added to the well plate prepared as 150 described above and incubated for 1 hr at 37 °C in an atmosphere of 5% CO2 and 95% humidity. After 1 hr, LPs were added and incubated for 3 additional hrs. The cells were washed 3 times with 1 ml of ice-cold phosphate buffer saline (PBS)
supplemented with heparin (20 units/ml) to completely remove the surface-bound KYND-PEG-LP and the fluorescence intensity of rhodamine was then 155 determined.
Inhibition assay in presence of unlabeled PEG-LPs modified with KYND
To investigate the involvement of the receptor in the cellular uptake pathway of KYND-PEG-LP, 40,000 HUVECs were seeded in a 24-well plate and the plate was 160 incubated overnight at 37 °C in an atmosphere of 5% CO2 and 95% humidity. Next day, 10 mol% KYND modified rhodamine labeled and unlabeled PEG-LPs were added using different concentrations (1:0, 1:5, 1:10, 1:20 and 1:50 respectively) and incubated for next 3 hrs. After 3 hrs, the cells were washed 3 times with 1 ml of ice-cold phosphate buffer saline (PBS) supplemented with heparin (20 units/ml) 165 to completely remove the surface-bound KYND-PEG-LP and the fluorescence intensity of rhodamine was then determined. Same experiment was conducted using R8 peptide grafted on the top of PEG of PEG-LPs (R8-PEG-LPs).
Inhibition assay in presence of inhibitors 170
To investigate the mechanism of internalization of KYND motif, 40,000 Hela cells were seeded in a 24-well plate (Corning incorporated, Corning, NY, USA) and the plate was incubated overnight at 37 °C in an atmosphere of 5% CO2 and 95%
humidity. Before transfection, the cells were washed with 1 ml of PBS and were pre-incubated with Kreb's buffer in the absence or presence of the following 175 inhibitors for various times: Amiloride (5 mM) for 30 min; Sucrose (1 M) for 30 min or Filipin III (400 g/ml) for 1 h at 37 °C (Mudhakir et al., 2007 , Khalil et al., 2004 , Hansen et al., 1993 . KYND modified PEG-LP was added and the cells were incubated for 1 hr at 37 °C in the presence or absence of inhibitors. The cells were washed 3 times with 1 ml of ice-cold phosphate buffer saline (PBS) supplemented 180 with heparin (20 units/ml) to completely remove the surface-bound KYND-PEG-LP and the fluorescence intensity of rhodamine was then determined, as described above.
Statistical analysis 185
Pair-wise comparisons of subgroups were made using a student's t-test.
Comparisons between multiple treatments were made using one-way analysis of variance (ANOVA), followed by the 'Dunnett test. Factorial analysis was done by two-way ANOVA. Differences among the means were considered to be statistically significant at a p-value of <0.05.
Results
Synthesis of KYND-PEG-DSPE
KYND-PEG2000-DSPE was synthesized after conjugation of the KYND peptide (calculated MW 1441.68 and observed MW 1444.04) with
Maleimide-PEG-DSPE (calculated Mn 2936) in water (Fig. 1A) . MS analyses were performed for the KYND peptide and
Maleimide-PEG-DSPE (Fig. 1B) , which confirmed that the conjugation was successful, as evidenced by the molecular shifts in the MALDI-TOF MS analysis (Fig. 1C) . observed between increments of KYND-PEG of 1 mol% to 5 mol% (Table 1) .
This increment in surface charge of the KYND-PEG-LPs is indicative of the cationic properties of the KYND peptide. To evaluate the effect of the KYND peptide on cellular uptake, we examine the cellular uptake efficiency of PEG-LPs that had been modified with the KYND peptide. In HUVEC, TEM8 220 positive cells, the findings indicated that PEGylation had a slight inhibitory effect on the cellular uptake of LPs, however the KYND peptide gradually enhanced the cellular uptake of PEG modified LPs and the maximum cellular uptake was observed for PEG-LPs modified with 10% KYND ( (Fig. 5A) . It was interestingly observed that the unlabeled R8-PEG-LPs have significant inhibitory effect on the cellular uptake of labeled R8-PEG-LPs (Fig. 5B) . After getting these results, the cellular 250 uptake of labeled KYND-PEG-LPs was also evaluated in presence of unlabeled R8-PEG-LPs and it was found that the cellular uptake of labeled KYND-PEG-LPs was surprisingly inhibited by R8-PEG-LPs (Fig. 5C ). The results generated in this study demonstrated that both of R8 peptide and KYND motif peptide are interacting with the same molecules present on the 255 cell surface. Therefore, it can be conferred that KYND motif peptide functions in a non-specific manner and no specific receptor is involved in the internalization process of KYND modified PEG-LPs.
3.3.3. Investigation of cellular uptake mechanism using inhibitors 260
The cellular uptake route of PEG-LP modified with KYND was investigated by evaluating the contribution of different endocytic pathways. Inhibitors that specifically block macropinocytosis, clathrin-mediated endocytosis and caveolar endocytosis were used to determine the mechanism of KYND-PEG-LP uptake. Specifically, a hypertonic medium (sucrose) was 265 used to inhibit clathrin-mediated endocytosis via dissociation of the clathrin lattice (Heuser and Anderson, 1989) . Amiloride inhibits macropinocytosis by inhibiting the Na + /H + exchange required for macropinocytosis (Hewlett et al., 1994) . Filipin inhibits caveolar uptake through cholesterol depletion (Lamaze and Schmid, 1995) . For this study, we prepared PEG-LPs modified 270 with 10 mol% of the KYND peptide. The cellular uptake of KYND-PEG-LP was inhibited by sucrose ( Fig. 6 ) but in contrast, the presence of amiloride or filipin did not inhibit the uptake of KYND-PEG-LP. This study reveals that KYND modified PEG-LPs were internalized into cells via clathrin-mediated endocytosis pathway. (STR-R8) on the surface of the LPs modified with 5 mol% PEG or KYND-PEG. The average diameter and -potential of R8 modified PEG-LP and R8 modified KYND-PEG-LP were 86 ± 1 nm and -20 ± 9 mV, and 92 ± 1 nm and 32 mV, respectively. The addition of STR-R8 on the surface of liposomes had no influence on particle diameter, and slightly increased the 295 -potential compared to liposomes without STR-R8 (Table 1) . As shown in Fig. 7 , R8 modification resulted in only a minor effect on the cellular uptake of PEGyalated LPs, presumably because the R8 moiety is not able to interact with the cell surface due to steric hindrance by the PEG layer, and the KYND mediated cellular uptake of PEG-LP was observed. In the dual-ligand 300 formulations modified with both KYND and R8, cellular uptake in all cell lines was greatly enhanced compared to KYND-PEG-LP, even though R8 was hindered by the PEG layer. These results suggest that a dual-ligand formulation comprised with two kinds of CPP ligands also exerted a synergistic effect on cellular association and uptake.
Discussion
It is well known that liposomes are very effective drug carriers for therapeutics. In a liposomal drug delivery system, polyethylene glycol (PEG)-modified liposomes are well known to be useful drug carriers for 310 cancer therapy for drugs such as Doxil, PEGylated liposomes encapsulating doxorubicin (Perez et al., 2002; Sekiya and Imamura, 2008; Minisini et al., 2008) . PEG modified liposomes have long-circulation time through avoidance of trapping by a reticuloendothelial system (RES) such as the liver and spleen (Sakakibara et al., 1996; Lasic, 1996) . Through the EPR effect based 
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Angiogenesis has an important role in tumor growth and metastasis.
Therefore, anti-angiogenic therapy by targeting tumor endothelial cells represents an attractive and important strategy in cancer therapy (Wu and Chang 2010; Chang et al., 2009; Ogawara et al., 2009; Corti and Ponzoni 2004) . In the present study, we attempted to create a novel targeting ligand 335 for TEM8 on tumor endothelial cells. It was reported that the protective antigen (PA) of the anthrax toxin from Bacillus anthracis has the ability to recognize TEM8 (Bradley et al., 2001; Scobie and Young, 2005) . Furthermore, domain 4 of PA (PA-D4) might be the optimal region for recognizing TEM8 (Singh et al., 1991; Brossier et al., 1999) . Based on the previous reports, we 340 designed a new peptide sequence, KKYNDKLPLY, derived from the PA-D4 which was predicted to act as a ligand for TEM8. The selected KYND peptide (Fig. 5A) . In this study, it was observed that the cellular uptake of KYND modified labeled PEG-LPs was inhibited by the addition of higher amount of KYND modified unlabeled PEG-LPs which 385 indicated that there might have any specific receptor responsible for interaction with KYND motif peptide. These results provided the contradictory idea about the findings of the inhibition study in presence of free KYND motif peptide (Fig.4) . Therefore, the same experiment has been performed using octaarginine (R8) peptide which is a well known CPP, as 390 shown in Fig. 5B . In this experiment, it was found that the cellular uptake of rhodamine labeled R8 modified PEG-LPs (R8-PEG-LPs) was remarkably inhibited after addition of unlabeled R8-PEG-LPs which might be due to the inhibition of electrostatic interactions of R8 peptide (present in labeled PEG-LPs) with cell surface molecules by higher concentration of R8 peptide 395 present in unlabeled PEG-LPs. After getting these results, the same experiments has also been conducted using rhodamine labeled KYND-PEG-LPs and unlabeled R8-PEG-LPs (Fig. 5C ). It was observed that the cellular uptake of KYND-PEG-LPs was significantly inhibited by the presence of higher concentration of R8 modified PEG-LPs. These results 400 indicated that both of KYND motif peptide and R8 peptide enhance the cellular uptake of PEG-LPs by sharing the same cell surface molecules. Upon considering the results obtained from these experiments, it can be concluded that the KYND peptide motif selected for use is not a specific ligand for TEM8, but, rather, a CPP. According to definition of CPP, CPP consists of 405 arginine or lysine residues Wender et al., 2000) and amino acids with bulky hydrophobic side chains (Rothbard et al., 2002) .
KYND peptide we selected is composed of lysine residues and hydrophobic amino acids such as leucine and proline. Taking these facts into consideration, contrary to expectation, it was assumed that the KYND motif 410 peptide acts not as a specific ligand for TEM8 but as a novel CPP peptide.
The internalization of KYND peptide was significantly inhibited when cells were incubated in presence of sucrose (Fig. 6) , which indicated that the internalization of new CPP is governed mainly by clathrin mediated endocytosis pathway. The selected sequence within PA-D4 of the anthrax 415 toxin might be responsible for the attachment with target molecules and invasion inside of cells rather than the selectivity of the anthrax toxin. It is expected that other regions of PA-D4 would generate the selectivity for TEM8. As a result of our study, we conclude that the KYND motif peptide from anthrax toxin is, in fact, a novel CPP. 420 We recently reported on the development of a dual-ligand liposomal formulation modified with a selective ligand and a CPP peptide as a cationic ligand (Takara et al., 2010) . Although targetability is achieved by introducing a specific ligand into the PEGylated liposomes, the amount of designed so as to control the topology of the functional devices to permitt their synergistic function. In the present study, we investigated whether a carrier designed with two types of CPP ligands would be applicable for a dual-ligand formulation by using a KYND motif peptide on the top of PEG and R8 as an oligoarigine on the surface of liposomes.
440
The relative values for cellular uptake derived form Fig. 7 were calculated and the results are shown in Table 2 . STR-R8 modification on the surface membrane of PEG-LP had negligible or minor effects on cellular uptake due to the inhibition of interactions of the R8 moiety with the cellular surface by 445 the PEG layer. On the other hand, KYND modification increased the cellular uptake of PEG-LP by 6-10-fold. Furthermore, in the case of a dual-ligand formulation (R8/KYND-PEG-LP), the efficiency of cellular uptake was 10-20-fold compared to PEG-LP (Fig. 7) . Additionally, factor analysis by two-way ANOVA finds the both KYND dependent (P<0.001) and R8 dependent (P<0.05) uptake, and also indicates the interaction (P<0.05) in three cells, which suggests the effect of R8 on cellular uptake is exerted mainly in the case of KYND-modified PEG-LP. It supposes that the dual-ligand formulation enhanced cellular uptake in a synergistic manner.
The synergistic effect may result from that the R8 moiety, which is masked Material and methods.
